ORIC Pharmaceuticals Inc. (ORIC) NASDAQ

$9.53 (0.27) (-2.76%)

Market Cap: $660.28M

As of 04/15/24 03:59 PM EDT. Market closed.

(ORIC)

ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ

$9.53
(0.27) (-2.76%)

Market Cap: $660.28M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

oric pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. its lead product candidate is oric-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. the company's second product candidate is oric-533, an ... read more

oric pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. its lead product candidate is oric-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. the company's second product candidate is oric-533, an orally bioavailable small molecule inhibitor of cd73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. it is also developing multiple precision medicines targeting other cancer resistance mechanisms. the company was founded in 2014 and is headquartered in south san francisco, california. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacob Chacko
Full Time Employees
86
URL
Address
240 E. Grand Ave., 2Nd Floor, California, South San Francisco, 94080.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacob Chacko
Full Time Employees
86
Address
240 E. Grand Ave., 2Nd Floor, California, South San Francisco, 94080.
PRICE CHART FOR ORIC PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.94
Previous Close
$9.80
Days Range
$9.60 - $9.91
52 week range
$4.89 - $16.65
Volume
332,113
Avg. Volume (30 days)
556,620
Market Cap
$660.28M
Dividend Yield
-
P/E
-
Shares Outstanding
67,375,847
Open
$9.94
Previous Close
$9.80
Days Range
$9.60 - $9.91
52 week range
$4.89 - $16.65
Volume
332,113
Avg. Volume (30 days)
556,620
Market Cap
$660.28M
Dividend Yield
-
P/E
-
Shares Outstanding
67,375,847
FINANCIAL STATEMENTS FOR ORIC PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ORIC PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Chacko JacobPRESIDENT AND CEOMar 06, 2024 Sale$16.2140,000648,380728,544Mar 08, 2024, 04:20 PM
Chacko JacobPRESIDENT AND CEOFeb 07, 2024 Sale$12.3026,042320,186768,544Feb 08, 2024, 08:01 PM
Chacko JacobPRESIDENT AND CEOFeb 06, 2024 Sale$12.1213,958169,160794,586Feb 08, 2024, 08:01 PM
Multani Pratik SChief Medical OfficerDec 15, 2023 Sale$8.595,28245,35123,809Dec 19, 2023, 07:42 PM
Piscitelli DominicChief Financial OfficerDec 15, 2023 Sale$8.585,28245,33883,809Dec 19, 2023, 07:40 PM
Chacko JacobPresident and CEODec 15, 2023 Sale$8.5814,539124,813808,544Dec 19, 2023, 07:39 PM
Chacko JacobPresident and CEOJul 11, 2023 Sale$8.015,15641,287780,652Jul 11, 2023, 09:28 PM
Chacko JacobPresident and CEOJul 10, 2023 Sale$8.0110,50884,212785,808Jul 11, 2023, 09:28 PM
Chacko JacobPresident and CEOJul 05, 2023 Sale$8.014,33634,711796,316Jul 07, 2023, 04:35 PM
Chacko JacobPresident and CEOJun 26, 2023 Sale$8.0320,000160,562800,652Jun 28, 2023, 07:18 PM
Multani Pratik SChief Medical OfficerDec 15, 2022 Sale$3.072,2276,8467,285Feb 17, 2023, 04:25 PM
Piscitelli DominicChief Financial OfficerDec 15, 2022 Sale$3.082,2276,85467,285Feb 17, 2023, 04:23 PM
Chacko JacobPresident and CEODec 15, 2022 Sale$3.076,13718,859816,652Feb 17, 2023, 04:22 PM
Multani Pratik SChief Medical OfficerDec 15, 2022 Sale$3.252,0896,7897,423Dec 16, 2022, 08:51 PM
Piscitelli DominicChief Financial OfficerDec 15, 2022 Sale$3.252,0896,78967,423Dec 16, 2022, 08:49 PM
Chacko JacobPresident and CEODec 15, 2022 Sale$3.255,76418,733817,025Dec 16, 2022, 08:47 PM
Chacko JacobPresident and CEOMay 11, 2022 Buy$2.90304,574883,569657,226May 13, 2022, 06:52 PM
Chacko JacobPresident and CEOMay 13, 2022 Buy$2.8276,072214,561802,652May 13, 2022, 06:52 PM
Chacko JacobPresident and CEOMay 12, 2022 Buy$2.7569,354190,467726,580May 13, 2022, 06:52 PM
Piscitelli DominicChief Financial OfficerMar 31, 2022 Buy$5.3660,000321,62460,000Mar 31, 2022, 08:51 PM
Chacko JacobPresident and CEOMar 25, 2022 Buy$4.5450,000227,170352,652Mar 25, 2022, 06:42 PM
Chacko JacobPresident and CEOMar 24, 2022 Buy$5.0342,873215,660302,652Mar 25, 2022, 06:42 PM
Chacko JacobPresident and CEOMar 23, 2022 Buy$4.98257,1271,280,878259,779Mar 25, 2022, 06:42 PM
COLUMN GROUP II, LP10% OwnerNov 12, 2021 Option Exercise$16.0016,625266,00016,625Nov 16, 2021, 04:49 PM
Heyman Richard A.DirectorSep 15, 2021 Sale$25.0368217,074216,272Sep 16, 2021, 06:19 PM
Heyman Richard A.DirectorSep 14, 2021 Sale$25.0570617,686216,954Sep 16, 2021, 06:19 PM
Chacko JacobPresident and CEOSep 15, 2021 Sale$25.063,73693,6292,652Sep 16, 2021, 06:17 PM
Chacko JacobPresident and CEOSep 14, 2021 Sale$25.054,420110,7066,388Sep 16, 2021, 06:17 PM
Heyman Richard A.DirectorSep 13, 2021 Sale$25.0160115,033217,660Sep 14, 2021, 04:03 PM
Heyman Richard A.DirectorSep 10, 2021 Sale$25.1047912,023218,261Sep 14, 2021, 04:03 PM
Chacko JacobPresident and CEOSep 13, 2021 Sale$25.022,80170,08910,808Sep 14, 2021, 04:01 PM
Chacko JacobPresident and CEOSep 10, 2021 Sale$25.082,94273,78313,609Sep 14, 2021, 04:01 PM
Heyman Richard A.DirectorSep 07, 2021 Sale$25.111,08627,272218,740Sep 09, 2021, 04:36 PM
Chacko JacobPresident and CEOSep 08, 2021 Sale$25.032005,00716,551Sep 09, 2021, 04:33 PM
Chacko JacobPresident and CEOSep 07, 2021 Sale$25.115,981150,17316,751Sep 09, 2021, 04:33 PM
SCHELLER RICHARD HDirectorMay 20, 2021 Sale$25.0865916,52840,423May 24, 2021, 07:29 PM
SCHELLER RICHARD HDirectorMay 24, 2021 Sale$25.001002,50039,092May 24, 2021, 07:29 PM
SCHELLER RICHARD HDirectorMay 21, 2021 Sale$25.191,23131,00839,192May 24, 2021, 07:29 PM
Heyman Richard A.DirectorMay 18, 2021 Sale$25.322,16154,715221,226May 18, 2021, 08:22 PM
Heyman Richard A.DirectorMay 17, 2021 Sale$25.0749812,484223,387May 18, 2021, 08:22 PM
Heyman Richard A.DirectorMay 14, 2021 Sale$25.313,21581,382223,885May 18, 2021, 08:22 PM
SCHELLER RICHARD HDirectorMay 14, 2021 Sale$25.384,615117,11744,382May 18, 2021, 08:20 PM
SCHELLER RICHARD HDirectorMay 18, 2021 Sale$25.342,80070,95841,082May 18, 2021, 08:20 PM
SCHELLER RICHARD HDirectorMay 17, 2021 Sale$25.0650012,53043,882May 18, 2021, 08:20 PM
Heyman Richard A.DirectorApr 30, 2021 Sale$25.261002,526227,200Apr 30, 2021, 07:59 PM
Heyman Richard A.DirectorApr 28, 2021 Sale$25.081002,508227,300Apr 30, 2021, 07:59 PM
Heyman Richard A.DirectorApr 01, 2021 Sale$25.001002,500227,400Apr 05, 2021, 07:42 PM
Chacko JacobPresident and CEOApr 01, 2021 Sale$25.0980020,07061,700Apr 05, 2021, 07:40 PM
GORDON CARL LDirectorMar 30, 2021 Sale$23.9327,869666,9052,212,571Mar 31, 2021, 05:11 PM
GORDON CARL LDirectorMar 29, 2021 Sale$23.3175,5551,761,1872,240,440Mar 31, 2021, 05:11 PM
ORBIMED ADVISORS LLCDirectorMar 30, 2021 Sale$23.9327,869666,9052,212,571Mar 31, 2021, 05:08 PM
ORBIMED ADVISORS LLCDirectorMar 29, 2021 Sale$23.3175,5551,761,1872,240,440Mar 31, 2021, 05:08 PM
ORBIMED ADVISORS LLCDirectorMar 26, 2021 Sale$23.8827,816664,2462,315,995Mar 26, 2021, 05:51 PM
ORBIMED ADVISORS LLCDirectorMar 25, 2021 Sale$24.7051,5231,272,6182,343,811Mar 26, 2021, 05:51 PM
ORBIMED ADVISORS LLCDirectorMar 24, 2021 Sale$24.8032,959817,3832,395,334Mar 26, 2021, 05:51 PM
GORDON CARL LDirectorMar 25, 2021 Sale$24.7051,5231,272,6182,343,811Mar 26, 2021, 05:46 PM
GORDON CARL LDirectorMar 24, 2021 Sale$24.8032,959817,3832,395,334Mar 26, 2021, 05:46 PM
GORDON CARL LDirectorMar 26, 2021 Sale$23.8827,816664,2462,315,995Mar 26, 2021, 05:46 PM
GORDON CARL LDirectorMar 23, 2021 Sale$24.323,99297,0852,428,293Mar 23, 2021, 05:26 PM
GORDON CARL LDirectorMar 22, 2021 Sale$26.477,673203,1042,432,285Mar 23, 2021, 05:26 PM
GORDON CARL LDirectorMar 19, 2021 Sale$26.4721,275563,1492,439,958Mar 23, 2021, 05:26 PM
ORBIMED ADVISORS LLCDirectorMar 22, 2021 Sale$26.477,673203,1042,432,285Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLCDirectorMar 19, 2021 Sale$26.4721,275563,1492,439,958Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLCDirectorMar 23, 2021 Sale$24.323,99297,0852,428,293Mar 23, 2021, 05:22 PM
ORBIMED ADVISORS LLCDirectorMar 18, 2021 Sale$28.036,059169,8342,461,233Mar 18, 2021, 09:07 PM
ORBIMED ADVISORS LLCDirectorMar 17, 2021 Sale$28.4318,790534,2002,467,292Mar 18, 2021, 09:07 PM
ORBIMED ADVISORS LLCDirectorMar 16, 2021 Sale$27.7241,3531,146,3052,486,082Mar 18, 2021, 09:07 PM
GORDON CARL LDirectorMar 16, 2021 Sale$27.7241,3531,146,3052,486,082Mar 18, 2021, 09:04 PM
GORDON CARL LDirectorMar 18, 2021 Sale$28.036,059169,8342,461,233Mar 18, 2021, 09:04 PM
GORDON CARL LDirectorMar 17, 2021 Sale$28.4318,790534,2002,467,292Mar 18, 2021, 09:04 PM
ORBIMED ADVISORS LLCDirectorMar 15, 2021 Sale$29.1489,2102,599,5792,527,435Mar 15, 2021, 08:55 PM
ORBIMED ADVISORS LLCDirectorMar 12, 2021 Sale$30.2990,5212,741,8812,616,645Mar 15, 2021, 08:55 PM
ORBIMED ADVISORS LLCDirectorMar 11, 2021 Sale$33.0458,5511,934,5252,707,166Mar 15, 2021, 08:55 PM
GORDON CARL LDirectorMar 11, 2021 Sale$33.0458,5511,934,5252,707,166Mar 15, 2021, 08:50 PM
GORDON CARL LDirectorMar 15, 2021 Sale$29.1489,2102,599,5792,527,435Mar 15, 2021, 08:50 PM
GORDON CARL LDirectorMar 12, 2021 Sale$30.2990,5212,741,8812,616,645Mar 15, 2021, 08:50 PM
ORBIMED ADVISORS LLCDirectorApr 24, 2020 Buy$16.00281,2504,500,000281,250Apr 28, 2020, 05:13 PM
GORDON CARL LDirectorApr 24, 2020 Buy$16.00281,2504,500,000281,250Apr 28, 2020, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Chacko JacobPRESIDENT AND CEO03/06/2024648,380
Chacko JacobPRESIDENT AND CEO02/07/2024320,186
Chacko JacobPRESIDENT AND CEO02/06/2024169,160
Multani Pratik SChief Medical Officer12/15/202345,351
Piscitelli DominicChief Financial Officer12/15/202345,338
Chacko JacobPresident and CEO12/15/2023124,813
Chacko JacobPresident and CEO07/11/202341,287
Chacko JacobPresident and CEO07/10/202384,212
Chacko JacobPresident and CEO07/05/202334,711
Chacko JacobPresident and CEO06/26/2023160,562
Multani Pratik SChief Medical Officer12/15/20226,846
Piscitelli DominicChief Financial Officer12/15/20226,854
Chacko JacobPresident and CEO12/15/202218,859
Multani Pratik SChief Medical Officer12/15/20226,789
Piscitelli DominicChief Financial Officer12/15/20226,789
Chacko JacobPresident and CEO12/15/202218,733
Chacko JacobPresident and CEO05/11/2022883,569
Chacko JacobPresident and CEO05/13/2022214,561
Chacko JacobPresident and CEO05/12/2022190,467
Piscitelli DominicChief Financial Officer03/31/2022321,624
Chacko JacobPresident and CEO03/25/2022227,170
Chacko JacobPresident and CEO03/24/2022215,660
Chacko JacobPresident and CEO03/23/20221,280,878
COLUMN GROUP II, LP10% Owner11/12/2021266,000
Heyman Richard A.Director09/15/202117,074
Heyman Richard A.Director09/14/202117,686
Chacko JacobPresident and CEO09/15/202193,629
Chacko JacobPresident and CEO09/14/2021110,706
Heyman Richard A.Director09/13/202115,033
Heyman Richard A.Director09/10/202112,023
Chacko JacobPresident and CEO09/13/202170,089
Chacko JacobPresident and CEO09/10/202173,783
Heyman Richard A.Director09/07/202127,272
Chacko JacobPresident and CEO09/08/20215,007
Chacko JacobPresident and CEO09/07/2021150,173
SCHELLER RICHARD HDirector05/20/202116,528
SCHELLER RICHARD HDirector05/24/20212,500
SCHELLER RICHARD HDirector05/21/202131,008
Heyman Richard A.Director05/18/202154,715
Heyman Richard A.Director05/17/202112,484
Heyman Richard A.Director05/14/202181,382
SCHELLER RICHARD HDirector05/14/2021117,117
SCHELLER RICHARD HDirector05/18/202170,958
SCHELLER RICHARD HDirector05/17/202112,530
Heyman Richard A.Director04/30/20212,526
Heyman Richard A.Director04/28/20212,508
Heyman Richard A.Director04/01/20212,500
Chacko JacobPresident and CEO04/01/202120,070
GORDON CARL LDirector03/30/2021666,905
GORDON CARL LDirector03/29/20211,761,187
ORBIMED ADVISORS LLCDirector03/30/2021666,905
ORBIMED ADVISORS LLCDirector03/29/20211,761,187
ORBIMED ADVISORS LLCDirector03/26/2021664,246
ORBIMED ADVISORS LLCDirector03/25/20211,272,618
ORBIMED ADVISORS LLCDirector03/24/2021817,383
GORDON CARL LDirector03/25/20211,272,618
GORDON CARL LDirector03/24/2021817,383
GORDON CARL LDirector03/26/2021664,246
GORDON CARL LDirector03/23/202197,085
GORDON CARL LDirector03/22/2021203,104
GORDON CARL LDirector03/19/2021563,149
ORBIMED ADVISORS LLCDirector03/22/2021203,104
ORBIMED ADVISORS LLCDirector03/19/2021563,149
ORBIMED ADVISORS LLCDirector03/23/202197,085
ORBIMED ADVISORS LLCDirector03/18/2021169,834
ORBIMED ADVISORS LLCDirector03/17/2021534,200
ORBIMED ADVISORS LLCDirector03/16/20211,146,305
GORDON CARL LDirector03/16/20211,146,305
GORDON CARL LDirector03/18/2021169,834
GORDON CARL LDirector03/17/2021534,200
ORBIMED ADVISORS LLCDirector03/15/20212,599,579
ORBIMED ADVISORS LLCDirector03/12/20212,741,881
ORBIMED ADVISORS LLCDirector03/11/20211,934,525
GORDON CARL LDirector03/11/20211,934,525
GORDON CARL LDirector03/15/20212,599,579
GORDON CARL LDirector03/12/20212,741,881
ORBIMED ADVISORS LLCDirector04/24/20204,500,000
GORDON CARL LDirector04/24/20204,500,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ORIC PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BlackRock Inc.2,995,0320.00084%-3.25%Other
GEODE CAPITAL MANAGEMENT, LLC874,8910.00084%6.64%Other
VIVO CAPITAL, LLC849,6810.64%9.22%Other
ORBIMED ADVISORS LLC522,9680.1%-41.48%Other
UBS OCONNOR LLC262,9560.17%-25.19%Value
RENAISSANCE TECHNOLOGIES LLC188,5000.00268%-50.37%Other
DRIEHAUS CAPITAL MANAGEMENT LLC143,9430.02%No changeGrowth
D. E. SHAW & CO., INC.98,4330.00079%-67.99%Other
AQR CAPITAL MANAGEMENT LLC14,1460.00024%26.31%Other
CHANGE IN SHARES OUTSTANDING FOR ORIC PHARMACEUTICALS INC
STOCK BUYBACKS FOR ORIC PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.22%
1Q
12/31/2023
06/30/2023
26.01%
2Q
12/31/2023
03/31/2023
27.59%
3Q
12/31/2023
12/31/2022
43.36%
4Q
12/31/2023
09/30/2022
45.37%
5Q
12/31/2023
06/30/2022
45.71%
6Q
12/31/2023
03/31/2022
45.90%
7Q
12/31/2023
12/31/2021
46.01%
8Q
12/31/2023
09/30/2021
47.48%
9Q
12/31/2023
06/30/2021
56.75%
10Q
12/31/2023
03/31/2021
56.84%
11Q
12/31/2023
09/30/2020
89.78%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
26.01%
2Q
03/31/2023
27.59%
3Q
12/31/2022
43.36%
4Q
09/30/2022
45.37%
5Q
06/30/2022
45.71%
6Q
03/31/2022
45.90%
7Q
12/31/2021
46.01%
8Q
09/30/2021
47.48%
9Q
06/30/2021
56.75%
10Q
03/31/2021
56.84%
11Q
09/30/2020
89.78%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ORIC PHARMACEUTICALS INC
LOADING...